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Abstract YvgO is a recently characterized antifungal
protein isolated from Bacillus thuringiensis SF361 that
exhibits a broad spectrum of activity and pH stability.
Customized colorimetric metabolic assays based on stan-
dard broth microdilution techniques were used to deter-
mine the variable tolerance of Byssochlamys fulva H25 and
Candida albicans 3153A to YvgO exposure under select
matrix conditions impacting cellular proliferation. Nor-
malization of the solution pH after antifungal challenge
expanded the available pH range under consideration
allowing for a comprehensive in vitro assessment of YvgO
efficacy. Indicator susceptibility was examined across an
array of elementary growth-modifying conditions, includ-
ing media pH, incubation temperature, ionic strength, and
carbohydrate supplementation. Under suboptimal temper-
ature and pH conditions, the indicator growth rate reduced,
and YvgO-mediated susceptibility was attenuated. While
YvgO association but not efficacy was somewhat influ-
enced by solution ionic strength, carbohydrate supple-
mentation was shown to be the most influential
susceptibility factor, particularly for C. albicans. Although
the specific choice of carbohydrate/nutrient supplement
dictated the extent of enhanced YvgO efficacy, D-glucose
additionally improved the association between antifungal
and target. Indeed, when exposed to YvgO under condi-
tions that lead to increased cellular proliferation, both
indicators displayed a stronger association and suscepti-
bility to YvgO when compared to carbohydrate-deprived
media or suboptimal incubation environments. With further
study, YvgO may have the capacity to function as a pro-
phylaxis for food safety and preservation, as well as a
pharmaceutical agent against opportunistic fungal patho-
gens either independently or in combination with other
established treatments applied to both livestock and human
health concerns.
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Introduction
Current antifungal methodologies for the clinical and food
safety fields are limited due to low therapeutic thresholds,
poor stability or efficacy, and increasing resistance [11, 14,
24]. As with antibacterial compounds, the need for new
antifungal compounds is becoming more relevant as clin-
ical and food-processing challenges continue to escalate. In
addition to producing the bacteriocin Thurincin H [30],
Bacillus thuringiensis SF361 produces and secretes YvgO,
a novel proteinaceous agent showing select antifungal
activity toward several genera of filamentous fungi
including Aspergillus, Byssochlamys, and Penicillium as
well as the pathogenic yeast Candida albicans [20]. To
gain a better understanding of the biological activity of
YvgO, two primary indicators, Byssochlamys fulva H25
and C. albicans 3153A, were selected due to their high
susceptibility, their relevance to either food or clinical
applications, and their dissimilar morphology.
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In our previous work, we reported that YvgO is stable
for at least 2 weeks at physiological and ambient temper-
atures and is neither acid nor alkali labile, surviving for at
least 2 weeks in solutions ranging from pH 3 through 12
[20]. In this initial study, after incubation, the activity of
YvgO was assessed through the dilution of titers upon solid
nutrient agar, rather than directly at the incubation test
conditions. Up to this point, the functionality of YvgO at
variable matrix composition or solution pH is unknown. As
such, the aims of the current study were threefold: (1)
determine the differential efficacy of YvgO against the
chosen indicators under variable solution pH, nutrient
supplementation, and other growth-modifying conditions,
(2) accomplish the previous goal using a straightforward
analytical method that can be readily adapted for protein-
aceous and variable pH systems, and (3) correlate specific
indicator response metrics to YvgO efficacy in an effort to
elucidate potential means of biological activity.
To meet objective one, the choice and style of assess-
ment outlined in objective two becomes critical. In regards
to the second objective, standardized broth dilution meth-
ods do provide defined guidelines for determining break-
point parameters and quality control measures but are only
validated for select antifungal agents against a limited set
of indicators [2]. Since we are interested in YvgO’s effect
upon select indicators under specific growth conditions, we
will need to be free from such narrow constraints and have
instead opted for an assay that gives a more detailed
response to antifungal activity. Similar to other colori-
metric susceptibility assays [16, 18], tetrazolium salt-based
methods are essentially a broth microdilution assay utiliz-
ing a colorimetric indicator for the quantitative comparison
of antimicrobial susceptibility, providing a more detailed
assessment over measurements of titers, diffusion tech-
niques, or broth dilution methods [4, 7, 13, 21] while also
suitably comparing to established standardized broth dilu-
tion methods [5, 6] outlined by the Clinical and Laboratory
Standards Institute (CLSI). To that end, an assay involving
the reduction of XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfo-
phenyl)-2H-tetrazolium-5-carboxanilide) [23] has been
optimized and modified to best assess the cytotoxic effi-
cacy of YvgO throughout an extended range of matrix
considerations against both model indicators. In addition,
this assay will provide essential quantitative measures of
EC50, YvgO/indicator association, and minimum inhibitory
concentration (MIC), permitting a more thorough charac-
terization of YvgO efficacy. This study does not attempt to
redefine standard antimicrobial testing procedures. Our
methodology requires the use of modified media formula-
tions and growth conditions that would need to deviate
from prescribed CLSI approaches. Also, as we are not
comparing the efficacy of YvgO against other antifungal
compounds, standard visual end point CLSI approaches to
antimicrobial testing have been used for comparative and
validation purposes only.
During the initial characterization of such a novel anti-
fungal compound with diverse applications ranging from
pharmaceutical agent to food protectant, developing an
understanding of its biological activity against sensitive
fungal strains is required. To initiate this line of research,
variable YvgO susceptibility was quantified based on the
influence of select matrix conditions typical of physiolog-
ical and food-based systems that affect indicator growth,
which as will be shown, affect YvgO efficacy.
Materials and Methods
Microbial Indicators, Media, and YvgO Antifungal
Protein Production
Two microorganisms of differential morphology but ele-
vated susceptibility were chosen to serve as the indicators
used to assess YvgO efficacy. A B. fulva H25 spore crop
(105 spores/ml) was prepared and stored as described pre-
viously [20]. C. albicans 3153A was maintained on potato
dextrose agar (3.9 % PDA, BD Difco; Franklin Lakes, NJ
USA) acidified to pH 3.5 with 10 % tartaric acid. To
develop an active culture, a single colony was transferred
to 5 mls of tryptic soy broth (3 % TSB, BD Difco; Franklin
Lakes, NJ USA) and incubated for 16 h at 30 C. These
media were chosen as they each can be simply modified as
needed to exploit potential differences in efficacy observed
upon each indicator being studied.
The semi-purified ([95 % purity) ammonium sulfate
precipitation fraction (40 % saturation of the supernatant
adjusted to pH 6) of YvgO was prepared as previously
described [20], resuspended in Milli-Q water (Millipore
Corporation; Bedford, MA USA), and generated within
1 day prior to use. The absence of synergistic or comple-
mentary activity in the semi-purified preparations was
verified against HPLC-purified YvgO.
Susceptibility assays were carried out using several
media (BD Difco; Franklin Lakes, NJ USA): [1] CAA,
3.0 % Casamino acids supplemented with 1.5 % yeast
extract, [2] PDB, 2.4 % potato dextrose broth; and [3] TSB,
3.0 % tryptic soy broth. Precise pH alterations and/or
carbohydrate supplementation were made as necessary.
The media for all optimizations and assays were filter
sterilized through a 0.2-lm polyethersulfone (PES) mem-
brane (Millipore Corporation; Bedford, MA USA).
XTT and Menadione
The XTT assay typically functions better when the reduc-
tion of the XTT substrate occurs in the presence of an
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electron-coupling reagent such as menadione (22). XTT
(Sigma-Aldrich; ST. Louis, MO USA) was dissolved in
Milli-Q water to a final working concentration of 2 mg/ml.
A 25 mM solution of menadione (Sigma-Aldrich; ST.
Louis, MO USA) was prepared directly in acetone and
diluted in Milli-Q water to a final working concentration of
250 lM. Each solution was filtered through a 0.2-lm PES
membrane and stored in amber vials at 4 C. Equal vol-
umes of each component was warmed to room temperature
and combined immediately prior to use.
Experimental Design and Optimization of XTT
Parameters
Assays were carried out in triplicate using sterile 96-well
flat bottom polystyrene microtiter plates (Costar; Corning,
NY USA) and analyzed using an MRXTC Revelation
microtiter plate reader (Dynex Technologies, Chantilly,
VA USA) set at 490 nm for XTT/menadione absorbance
and 600 nm for XTT-independent monitoring of fungal
cell growth and calculation of cellular proliferation rates.
While incubations for all stages of optimization were ini-
tially examined at both 30 and 37 C, subsequent opti-
mized analyses were carried out at 30 C.
During XTT assay optimization, initial indicator den-
sities were varied from 102 to 105 cfu/ml, while XTT and
menadione concentrations were assessed from 25 to
200 lg/ml and 0 to 125 lM, respectively. Indicator
growth periods and post XTT incubation periods were
optimized based on the differential growth rate between
each indicator. In order to assess the amount of growth
after XTT/menadione addition all wells were examined
visually and at 600 nm in an XTT-independent fashion.
In doing so, there is a direct comparison between the
quantitative XTT assay and a visual method of detection
dictated by the CLSI [4, 21, 26]. Incubations for the
optimizations were performed with CAA media adjusted
to pH 6.
The optimized XTT assay consisted of 150 ll aliquot of
105 cfu/ml indicator combined with 50 ll of the twofold
serially diluted antifungal preparation. Fifty microliters of
sterile water in place of the antifungal served as the unre-
stricted growth control (theoretical maximum), while
sterile media in place of the inoculant served as the neg-
ative growth control (theoretical minimum). B. fulva spores
were incubated at 30 C for 24 h, while C. albicans was
incubated at 30 C for 6 h. Following incubation, 50 ll of
XTT/menadione was added (final concentrations 200 lg/
ml, 25 lM, respectively) and incubated for 2 h (B. fulva) or
30 min (C. albicans). Plates were read after a 15 min
incubation following a 25 ll 1 M phosphate buffer addi-
tion, described below.
Effect of Matrix pH on the Reliability and Feasibility
of the XTT Assay
The complication with assessing a pH-variable system with
tetrazolium salts is twofold: (1) the absorbance from
reduced XTT is maximal at pH 6.2, decreasing substan-
tially at lower pH values and (2) the background absor-
bance due to matrix interference is unacceptably high at
elevated pH. To adapt the technique to suit the current
study’s needs and expand the general utility of the assay,
the pH of the base media was varied integrally from 3 to 10
to assess the growth rate of each indicator and determine
the pH-sensitive effectiveness of XTT/menadione. The
indicator growth as measured at 600 nm, matrix back-
ground absorbance, and XTT-generated signal of each pH-
adjusted media was compared against a second set of wells
receiving 25 ll of 1 M phosphate buffer (pH 6.2), added
either before or after XTT/menadione incubation. Dupli-
cate XTT-free wells were inspected visually and also
measured at 600 nm as an XTT-independent assessment of
fungal growth and YvgO susceptibility. This led to the final
optimized procedure described in the previous section.
YvgO Efficacy as Dictated by Incubation Media pH
Due to growth restrictions, the pH-dependent susceptibility
of each indicator was determined integrally from pH 3 to 8
in CAA media. The starting concentration of the YvgO
dilution series was 25 lg/ml and 1,600 lg/mL for B. fulva
and C. albicans, respectively. It was determined experi-
mentally that the pH of each well did not vary significantly
due to antifungal addition or indicator growth during the
assay time span.
YvgO Efficacy due to Media and Carbohydrate
Supplement
For each indicator, three primary media were used to assess
susceptibility: (1) CAA, (2) PDB, and (3) TSB, as descri-
bed earlier. In addition, both indicators were tested against
CAA media supplemented with either 5 or 20 g/L of either
D-glucose or mannose (Fisher Scientific; Pittsburgh, PA
USA). Additionally, each of these formulations were tested
integrally from pH 3 to 8.
YvgO Efficacy due to Altered Solution Ionic Strength
In a similar fashion, the base CAA media was supple-
mented with increasing concentrations of sodium chloride
(Fisher Scientific; Pittsburgh, PA USA). The ionic strength
of the media was varied from 25 to 200 mM. Throughout
this range, indicator susceptibility was assessed at pH 3.5,
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6.0, and 7.4 in the presence or absence of 20 g/L D-glucose
or mannose.
Data Analysis and Statistical Interpretation
Indicator proliferation was described as normalized percent
growth, the maximum defined as the YvgO-free control.
The fungi-free wells served as the zero-signal background.
The sigmoidal curves generated from the YvgO-mediated
growth response were analyzed using a nonlinear, four
parameter Emax regression model [8–10] with a variable
slope and no preset constrictions on sigmoidal curve min-
imums or maximums, described by the equation:
y ¼ a þ ðb  aÞ=ð1 þ 10ððxcÞdÞÞ ð1Þ
where ‘‘a’’ is the theoretical minimum of the sigmoidal
curve; ‘‘b’’ is its theoretical maximum; ‘‘c’’ is the log EC50
(the concentration of antifungal required to reduce growth
by 50 % from the theoretical maximum); and ‘‘d’’ is the
slope, a convenient measure of the strength of association
between the indicator and YvgO. As mathematically
described, the slope would generate a negative value.
However, for clarity, all slopes are given as absolute
values.
Sigmoidal curves were described as an average of three
independent experiments each performed in triplicate, with
a standard deviation about the mean. EC50 and slopes were
statistically described using the 95 % confidence interval
(CI) range. The lowest concentration of YvgO restricting
growth to no more than 5 % over the background control
was defined as the MIC. These were additionally confirmed
visually using simple broth dilution methods. Treatment
comparisons were performed using one-way analysis of
variance (ANOVA) and the Tukey’s HSD test. Correlations
between solution pH, susceptibility within data sets, and
between YvgO efficacy and cellular proliferation were
described using Spearman’s rank correlation test.
Results and Discussion
There were no significant differences during optimization
or subsequent treatments within trials incubated at 30 and
37 C. Therefore, for ease of explanation, and to ensure
that hyphal growth in C. albicans is prevented, all pre-
sented data reflects the 30 C incubation trials. However,
when compared between 30 and 37 C, elevated incubation
temperatures resulted in decreased indicator doubling
times, resulting in decreased EC50 and MIC values. Details
for the XTT optimization protocol follow the YvgO/
microbe interaction study.
YvgO Efficacy as Dictated by Incubation Media pH
Figure 1 (B. fulva, top; C. albicans, bottom) depicts the
graphical illustration of the YvgO-mediated susceptibility
of each indicator from pH 3 to 8, using non-supplemented
CAA. Illustrations such as this offer a visual assessment of
both the efficacy (EC50 and MIC) and antifungal/indicator
association (slope). The corresponding quantitative account
of these parameters is found at the top of Tables 1 (B.
fulva) and 2 (C. albicans). B. fulva response shows
Fig. 1 XTT-determined growth curves as influenced by incubation
media pH generated by B. fulva H25 (a) and C. albicans 3153A
(b) exposed to serially diluted additions of the YvgO antifungal
protein. Each trial was performed using CAA as the only comparative
media. All points are presented as a percentage of growth normalized
from a theoretical maximum taken from control samples lacking
YvgO antifungal. Data points are means of triplicate trials given with
standard deviations about the mean
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significant deviations in EC50 at pH 8 (a = 0.01) and pH 3
(a = 0.05). This increase in pH was correlated (a = 0.05)
with decreasing YvgO association, which was further
correlated (a = 0.05) to decreases in cellular proliferation
rate. While C. albicans failed to show pH-mediated dif-
ferences in susceptibility, significantly decreased slopes
(a = 0.05) and MICs (a = 0.01) were observed when
compared to B. fulva.
YvgO Efficacy Due to Media and Carbohydrate
Supplement
Variations in carbohydrate concentration were not signifi-
cantly different. Tables 1 and 2 also describes the nonlinear
regression analysis for B. fulva and C. albicans, respec-
tively, as dictated by media supplementation. B. fulva
incubated in PDB or CAA media supplemented with glu-
cose or mannose (both 5 and 20 g/L) had no statistically
significant changes in susceptibility over non-supple-
mented controls at any pH tested. As these supplements did
not appreciably alter the growth rate of B. fulva, a corre-
lation between cellular proliferation and antifungal
concentration was not observed. Furthermore, when incu-
bated in carbohydrate-rich media, the previously observed
correlation between media pH and antifungal association
was lost, most likely due to observed normalized growth
rates.
The data sets for C. albicans are more informative.
There is a distinct alteration in both YvgO efficacy and
association as the carbohydrate source was varied. The
base CAA media lacking a carbohydrate supplement dis-
played the poorest YvgO efficacy (Fig. 1b) along with the
poorest cellular proliferation rate. Mannose-supplemented
media increased the efficacy approximately fourfold, while
the association between the antifungal and yeast remained
unchanged. There was a far better increase in YvgO
association when the CAA media was supplemented with
D-glucose. A visual interpretation of the differences
between the mannose supplement (Fig. 2a) and the D-glu-
cose supplement (Fig. 2b) is noteworthy. However, the
strongest association and efficacy against C. albicans was
observed with PDB (Fig. 2c). In this case, the EC50 and
MIC decreased significantly (a = 0.01) while the slopes
were improved over non-supplemented and mannose-
Table 1 Nonlinear regression analysis of B. fulva H25 susceptibility to YvgO under variable nutrient conditions
Media Condition Visual MICa
(lg/ml)
XTT MIC
(lg/ml)
EC50
b (95 % CIc, lg/ml) Slope (95 % CI,
absolute value)
CAAd, no supplement pH 3 3.13 1.56 0.864 (0.837–0.892) 2.153 (1.991–2.314)
pH 4 3.13 1.56 0.570 (0.564–0.575) 1.227 (1.194–1.259)
pH 5 3.13 1.56 0.446 (0.391–0.508) 1.145 (0.877–1.414)
pH 6 3.13 1.56 0.514 (0.459–0.576) 1.158 (0.943–1.373)
pH 7 3.13 1.56 0.411 (0.392–0.431) 0.775 (0.706–0.844)
pH 8 6.25 6.25 1.700 (1.675–1.726) 0.882 (0.834–0.931)
CAA ? 20 g/L mannose pH 3 3.13 1.56 0.614 (0.570–0.662) 1.941 (1.430–2.453)
pH 4 3.13 1.56 0.551 (0.434–0.700) 2.077 (1.671–2.483)
pH 5 3.13 1.56 0.581 (0.482–0.700) 2.637 (2.310–2.964)
pH 6 3.13 1.56 0.531 (0.509–0.555) 1.665 (1.487–1.843)
pH 7 3.13 6.25 0.762 (0.568–1.024) 1.105 (0.480–1.550)
pH 8 6.25 6.25 0.607 (0.586–0.628) 0.617 (0.578–0.657)
PDBe, no supplement pH 3 3.13 3.13 0.536 (0.399–0.719) 0.572 (0.310–0.833)
pH 4 1.56 1.56 0.851 (0.569–1.274) 1.614 (1.202–2.027)
pH 5 1.56 1.56 0.636 (0.483–0.837) 0.888 (0.622–1.154)
pH 6 1.56 1.56 0.745 (0.721–0.771) 1.562 (1.439–1.685)
pH 7 1.56 1.56 1.025 (0.937–1.121) 3.994 (3.394–4.594)
pH 8 3.13 1.56 0.669 (0.597–0.749) 1.019 (0.934–1.105)
All values represent the average of three independent experiments each performed in triplicate, with a standard deviation about the mean
a Minimum inhibitory concentrations (MIC) were taken as the last dilution of antifungal to show no appreciable increase (5 %) in cell growth
over cell-free controls
b EC50 = effective concentration of antifungal required to reduce cell growth by 50 %
c CI = confidence interval
d CAA = Casamino acids minimal media as described in text
e PDB = standard potato dextrose agar
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supplemented CAA (a = 0.01). Not surprisingly, a corre-
lation between efficacy and proliferation rate is observed
(a = 0.01) as the growth rate of C. albicans increases
throughout this series. Interestingly, TSB (commercially
formulated with 5 g/L glucose) displayed similar efficacy
to CAA supplemented with glucose, while dextrose-sup-
plemented CAA did not perform as well as PDB (com-
mercially formulated with 20 g/L dextrose).
In effect, the most efficacious response to YvgO
occurred when solution conditions favored rapid indicator
proliferation. In B. fulva, at higher pH values, growth was
impeded and the efficacy of YvgO diminished, even though
the association between YvgO and indicator remained
generally unchanged. When offered a media with a car-
bohydrate source as opposed to a starvation-style media, C.
albicans grew markedly faster, was more strongly
associated with YvgO, and became more susceptible.
While mannose conferred a faster cellular proliferation rate
that correlated with increased susceptibility, the addition of
the preferentially metabolized D-glucose [28] resulted in
the most robust proliferation rate and strongest antifungal
efficacy. This mirrors other lines of research indicating that
glucose, as opposed to mannose, is primarily responsible
for cell growth, metabolism and other regulatory factors in
many strains of yeast [17, 19, 25].
Ionic Strength Considerations
Along with changes in solution pH, the ionic strength of the
surrounding matrix can influence the electrostatic interac-
tions between a protein antagonist such as YvgO and the
cell surface of its intended target [1, 12]. For toxins that
Table 2 Nonlinear regression analysis of C. albicans 3153A susceptibility to YvgO under variable nutrient conditions
Media Condition Visual MIC a
(lg/ml)
XTT MIC
(lg/ml)
EC50
b (95 % CI c, lg/ml) Slope (95 % CI,
absolute value)
CAAd, no supplement pH 3 1,600 1,600 66.46 (51.38–85.96) 0.280 (0.232–0.329)
pH 4 1,600 1,600 199.7 (185.0–215.6) 0.345 (0.316–0.374)
pH 5 800 800 130.9 (115.6–148.1) 0.308 (0.280–0.337)
pH 6 800 800 207.1 (192.7–222.5) 0.698 (0.626–0.770)
pH 7 1,600 1,600 304.5 (230.7–401.9) 0.275 (0.235–0.316)
pH 8 1,600 1,600 68.18 (60.86–76.37) 0.265 (0.243–0.287)
CAA ? 20 g/L mannose pH 3 800 800 48.23 (44.22–52.62) 0.316 (0.282–0.349)
pH 4 400 200 18.37 (15.35–21.99) 0.338 (0.296–0.380)
pH 5 200 200 17.94 (15.66–20.54) 0.350 (0.324–0.377)
pH 6 200 200 40.04 (17.93–42.26) 0.558 (0.506–0.610)
pH 7 200 200 23.68 (21.61–25.94) 0.562 (0.518–0.606)
pH 8 200 200 14.84 (13.15–16.76) 0.517 (0.404–0.630)
CAA ? 20 g/L D-glucose pH 3 50 50 17.01 (16.68–17.36) 1.920 (1.818–2.021)
pH 4 100 50 23.80 (22.09–25.68) 0.796 (0.692–0.901)
pH 5 100 100 37.88 (28.97–49.53) 0.544 (0.375–0.712)
pH 6 100 100 48.06 (46.56–49.61) 0.852 (0.782–0.922)
pH 7 100 100 51.25 (50.00–52.53) 1.549 (1.461–1.636)
pH 8 100 100 36.95 (34.88–39.15) 0.959 (0.888–1.029)
PDBe, no supplement pH 3 50 50 19.12 (15.84–23.08) 0.698 (0.554–0.841)
pH 4 50 50 22.43 (21.66–23.21) 1.197 (1.120–1.273)
pH 5 25 25 8.372 (5.485–11.78) 0.651 (0.450–0.852)
pH 6 25 25 10.56 (6.478–17.20) 0.708 (0.450–0.966)
pH 7 25 25 12.57 (9.556–16.53) 0.891 (0.616–1.166)
pH 8 25 25 9.957 (7.677–12.91) 1.394 (0.322–2.466)
All values represent the average of three independent experiments each performed in triplicate, with a standard deviation about the mean
a Minimum inhibitory concentrations (MIC) were taken as the last dilution of antifungal to show no appreciable increase (5 %) in cell growth
over cell-free controls
b EC50 = effective concentration of antifungal required to reduce cell growth by 50 %
c CI = confidence interval
d CAA = Casamino acids minimal media as described in text
e PDB = standard potato dextrose agar
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utilize such an initial mode of attachment, disrupting this
process would subsequently affect the adsorption and
toxicity to the target cell. Assessments were difficult above
an ionic strength [100 mM as indicator growth suffered
and required increased incubation time to achieve reliable
results. Media tested at physiologically relevant conditions
of pH and ionic strength resulted in a similar efficacy
against each indicator. At pH 6, there were no statistically
relevant alterations in EC50 or MIC values when comparing
indicator susceptibility in media of varying ionic strength,
with or without carbohydrate supplementation. Regardless
of carbohydrate supplementation, under acidic conditions
(pH 3.5), an increased ionic strength resulted in a reduced
rate of growth, which in turn, resulted in moderately
reduced slopes (a = 0.05). In general, increasing ionic
strength typically resulted in a decreased association
between YvgO and its target (i.e., decreased slope). As this
could have consequences for cell wall attachment or
internalization, several lines of inquiry are currently
underway.
XTT Optimization for pH-Variable Matrices
The XTT metabolic assay provided a great deal of infor-
mation relevant for this study but suffered from a limited
utility. In order to expand the pH range and better reflect
the varied chemistries seen in food-based matrices, a pH
modification step needed to be added and thoroughly val-
idated. Furthermore, the assay needed to be validated for
the novel use of a proteinaceous antimicrobial agent with a
potentially pH-sensitive efficacy depending upon the tox-
in’s pKa and its ability to interact with specific microbial
indicators. The initial optimization strategy was adapted
from work performed with amphotericin B and itraconaz-
ole against specific Aspergillus spp. [22]. An analysis of
the indicator density, XTT/menadione concentration, and
incubation times that led to the described optimized
method is provided in supplemental Figures S1, S2, and S3.
The specific conditions chosen (Fig. 3) conferred the
strongest signals and lowest standard deviations for the
current study. The optimization protocol, when repeated
with other proteinaceous antimicrobials (i.e., bacteriocins)
against different indicators (i.e., bacilli, lactobacilli), is
easily customized for alternate toxin/microbe combinations
bFig. 2 XTT-determined growth curves as influenced by alterations in
media and carbohydrate supplement generated by C. albicans 3153A
exposed to serially diluted additions of the YvgO antifungal protein.
a CAA supplemented with 20 g/L mannose; b CAA supplemented
with 20 g/L D-glucose; c potato dextrose broth (PDB). All points are
presented as a percentage of growth normalized from a theoretical
maximum taken from control samples lacking YvgO antifungal. Data
points are the average of three independent experiments each
performed in triplicate, with a standard deviation about the mean
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and under various physiological and food-based matrices.
This utility is further expanded with post incubation
modification of solution pH, as described below.
At lower pH values, reduced XTT is protonated and fails
to give an appreciable signal at any visible wavelength
(Fig. 4a, B. fulva; c, C. albicans) even though there is
sufficient indicator growth up to pH 8 (Fig. 4b, B. fulva; d,
C. albicans). At a higher pH, the increased matrix back-
ground signal becomes problematic. While the pH buffer
can be introduced either prior to or after XTT/menadione
addition, the timing of the addition was not important as
each resulted in a complete recovery of XTT absorbance,
regardless of initial incubation pH (Fig. 4, right). In this
fashion, XTT can be a reliable indicator of the remaining
cell population after YvgO exposure, while normalizing the
reduced XTT signal to its maximum absorbance. Further-
more, under these conditions the signal due to XTT
absorbance was statistically similar to the indicator growth
determined visually by simple broth dilution methods.
Therefore, from a method development standpoint, this
study offers the added benefit of expanding the use of the
XTT assay as a means for the rapid metabolic screening of
several quantitative metrics of antimicrobial efficacy,
including in vitro testing at variable matrix pH (Fig. 4).
Concluding Remarks
The biological activity of YvgO appears similar to other
cytotoxic compounds that exploit upregulated mechanisms
of cellular metabolism and growth observed in rapidly
proliferating cells. The relationship between cellular pro-
liferation and cytotoxicity is well documented in areas
concerning chemotherapy and cell cycle metabolism [29].
Already shown to be adaptable to fungi [22] and yeast
such as Candida spp. [3, 15], using the modifications to the
XTT assay, a direct quantification of the proliferation-
dependent efficacy of YvgO across all viable solution pHs
is described. As the XTT assay relies on metabolically
active cells to measure cytotoxicity, a strong correlation
between YvgO efficacy and cellular proliferation can be
established. The expansion of this assay to include a wider
Fig. 3 Optimized XTT method
parameters for YvgO-based
efficacy trials against B. fulva
H25 and C. albicans 3153A.
The top shows the concurrent
optimization of XTT and
menadione response to B. fulva
(a) or C. albicans (b) indicator.
The bottom illustrates the
response of the idealized XTT
concentration across varying
concentrations of menadione
and initial spore/cell densities
for B. fulva (c) and C. albicans
(d). These trials utilized
optimized indicator incubation
times of 24 and 6 h for B. fulva
and C. albicans, respectively,
and XTT/menadione exposure
incubation times of 120 and
30 min for B. fulva and C.
albicans, respectively. Shaded
areas indicate the chosen
parameters used in the current
study. The complete
optimization protocol can be
found by referring to
supplemental Figures. 1–3
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pH range will be of interest to the fruit juice and beverage
industries where heat-resistant molds are often a concern in
various acidic commodities [27].
This study offers the first considerations concerning the
biological activity for YvgO based on cellular proliferation
correlations. As a complement to these initial studies,
collaborative work to elucidate YvgO’s tertiary structure
based on 3D NMR analysis in order to compare structure–
activity relationships is forthcoming. Widening the search
for natural antimicrobials and preservatives is imperative.
Proteinaceous compounds of this sort offer unique selec-
tivity that may be exploited in several scientific disciplines.
Due to its robust nature and efficacy, clinical and industrial
applications for the YvgO protein are promising. In the
food industry, YvgO could see significance in liquid-based
commodities that suffer from spoilage to due heat-resistant
molds such as B. fulva or contamination from mycotoxin
producing molds such as Penicillium spp. and Aspergillus
spp. As YvgO is efficacious in model physiological solu-
tions, an inquiry into potential cross-sensitivity to mam-
malian cell lines and synergistic interactions with
established antifungal pharmaceuticals is currently under-
way. Furthermore, in an effort to reduce the effective
dosage of relatively toxic antifungal pharmaceuticals, the
role of YvgO as a potential complementary cofactor for
established antifungal therapies is also being explored.
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